1666P Lower virus neutralizing titers against SARS-CoV-2 Omicron strain after third dose BNT162b2 following primo-vaccination with ChAdOx1 versus BNT162b2 in cancer patients

por Debie, Y., Van Audenaerde, J., Vandamme, T., Croes, L., Teuwen, L-A.M.N., Verbruggen, L., Vanhoutte, G., Marcq, E., Le Blon, D., Peeters, B., M.E. Goossens, Arien, K., Anguille, S., Smits, E., Vulsteke, C., Lion, E., Peeters, M., van Dam, P.A.
Publicado 2022